Review
Accepted on 30 Aug 2024
HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future
in Pharmacology of Anti-Cancer Drugs
Review
Accepted on 30 Aug 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 30 Aug 2024
in Neuropharmacology
Review
Accepted on 30 Aug 2024
in Intestinal Microbiome
Original Research
Accepted on 30 Aug 2024
in Sport Psychology
Original Research
Accepted on 30 Aug 2024
in Ethnopharmacology
Correction
Accepted on 30 Aug 2024
in Reproduction
Original Research
Accepted on 30 Aug 2024
in Positive Psychology
Original Research
Accepted on 30 Aug 2024
in Oral and Maxillofacial Surgery
Original Research
Accepted on 30 Aug 2024
in Cancer Epidemiology and Prevention
Review
Accepted on 30 Aug 2024
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 30 Aug 2024
in RNA
Original Research
Accepted on 30 Aug 2024
in Global Biodiversity Threats
Original Research
Accepted on 30 Aug 2024
in Sustainable Energy Systems
Original Research
Accepted on 30 Aug 2024
in Smart Grids
Original Research
Accepted on 30 Aug 2024
in Physical Education and Pedagogy
Perspective
Accepted on 30 Aug 2024
in Molecular Signalling and Pathways